Location matters: cellular heterogeneity in the hepatic lobule and hepatocellular carcinoma

被引:5
作者
Cunningham, Rory P. [1 ]
Kang, Sun Woo Sophie [1 ]
Porat-Shliom, Natalie [1 ]
机构
[1] NCI, Thorac & GI Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20814 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2023年 / 324卷 / 04期
关键词
hepatic lobule; heterogeneity; liver cancer; liver zonation; LIVER; ZONATION; PATHWAY; ACTIVATION; EXPRESSION; LANDSCAPE; PHENOTYPE; APC;
D O I
10.1152/ajpgi.00278.2022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tumor heterogeneity is a hallmark of cancer but a challenging problem to dissect mechanistically. Less recognized is that cells within normal tissues are also remarkably diverse. Hepatocytes are a great example because their spatial positioning and the local microenvironment govern their genetic heterogeneity. Recent studies show that primary liver tumors display heterogeneity similar to that observed in the normal tissue providing clues to the cellular precursor of the tumor and how variations in the lobule microenvironment support tumor formation and aggressiveness. Identifying the principles that control cellular diversity in a healthy liver may highlight potential mechanisms driving hepatic tumor heterogeneity.
引用
收藏
页码:G245 / G249
页数:5
相关论文
共 27 条
[1]   LKB1 acts as a critical brake for the glucagon-mediated fasting response [J].
Acevedo-Acevedo, Suehelay ;
Stefkovich, Megan L. ;
Kang, Sun Woo Sophie ;
Cunningham, Rory P. ;
Cultraro, Constance M. ;
Porat-Shliom, Natalie .
HEPATOLOGY COMMUNICATIONS, 2022, 6 (08) :1949-1961
[2]   Lgr5+ pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis [J].
Ang, Chow Hiang ;
Hsu, Shih Han ;
Guo, Fusheng ;
Tan, Chong Teik ;
Yu, Victor C. ;
Visvader, Jane E. ;
Chow, Pierce K. H. ;
Fu, Nai Yang .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (39) :19530-19540
[3]   Apc tumor suppressor gene is the "zonation-keeper" of mouse liver [J].
Benhamouche, Samira ;
Decaens, Thomas ;
Godard, Cecile ;
Chambrey, Regine ;
Rickman, David S. ;
Moinard, Christophe ;
Vasseur-Cognet, Mireille ;
Kuo, Calvin J. ;
Kahn, Axel ;
Perret, Christine ;
Colnot, Sabine .
DEVELOPMENTAL CELL, 2006, 10 (06) :759-770
[4]   Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner [J].
Berardi, Damian E. ;
Bock-Hughes, Althea ;
Terry, Alexander R. ;
Drake, Lauren E. ;
Bozek, Grazyna ;
Macleod, Kay F. .
SCIENCE ADVANCES, 2022, 8 (41)
[5]   Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas [J].
Colnot, S ;
Decaens, T ;
Niwa-Kawakita, M ;
Godard, C ;
Hamard, G ;
Kahn, A ;
Giovannini, M ;
Perret, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17216-17221
[6]   Liver Zonation - Revisiting Old Questions With New Technologies [J].
Cunningham, Rory P. ;
Porat-Shliom, Natalie .
FRONTIERS IN PHYSIOLOGY, 2021, 12
[7]   β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma [J].
de Galarreta, Marina Ruiz ;
Bresnahan, Erin ;
Molina-Sanchez, Pedro ;
Lindblad, Katherine E. ;
Maier, Barbara ;
Sia, Daniela ;
Puigvehi, Marc ;
Miguela, Vernica ;
Casanova-Acebes, Maria ;
Dhainaut, Maxime ;
Villacorta-Martin, Carlos ;
Singhi, Aatur D. ;
Moghe, Akshata ;
von Felden, Johann ;
Grinspan, Lauren Tal ;
Wang, Shuang ;
Kamphorst, Alice O. ;
Monga, Satdarshan P. ;
Brown, Brian D. ;
Villanueva, Augusto ;
Llovet, Josep M. ;
Merad, Miriam ;
Lujambio, Amaia .
CANCER DISCOVERY, 2019, 9 (08) :1124-1141
[8]   Human Hepatocellular Carcinomas With a Periportal Phenotype Have the Lowest Potential for Early Recurrence After Curative Resection [J].
Desert, Romain ;
Rohart, Florian ;
Canal, Frederic ;
Sicard, Marie ;
Desille, Mireille ;
Renaud, Stephanie ;
Turlin, Bruno ;
Bellaud, Pascale ;
Perret, Christine ;
Clement, Bruno ;
Le Cao, Kim-Anh ;
Musso, Orlando .
HEPATOLOGY, 2017, 66 (05) :1502-1518
[9]   Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments [J].
Ding, Jennifer ;
Karp, Judith E. ;
Emadi, Ashkan .
CANCER BIOMARKERS, 2017, 19 (04) :353-363
[10]   METABOLIC ZONATION OF THE LIVER - REGULATION AND IMPLICATIONS FOR LIVER-FUNCTION [J].
GEBHARDT, R .
PHARMACOLOGY & THERAPEUTICS, 1992, 53 (03) :275-354